The MLPA test for BRCA1 mutation could be recommended for breast cancer patients with a family member with breast and/or ovarian cancer and additional personal factors, and who tested negative for BRCA1/2 small mutations in initial testing. Here, BRCA1 is linked to ovarian carcinoma.